Association of Coronary Artery Anatomical Variations with Myocardial Fibrosis and Interventional Outcomes
DOI:
https://doi.org/10.53350/pjmhs020231711590Keywords:
Coronary artery variations, myocardial fibrosis, myocardial bridging, coronary angiography, interventional cardiology.Abstract
Background: Coronary artery anatomical variations are frequently encountered during diagnostic coronary angiography and interventional cardiac procedures. Although traditionally considered incidental, emerging evidence suggests that altered coronary anatomy may influence myocardial perfusion and contribute to subclinical myocardial remodeling. Myocardial fibrosis represents an early marker of adverse myocardial change and carries important prognostic implications.
Objective: To evaluate the association between coronary artery anatomical variations, myocardial fibrosis, and interventional outcomes in patients undergoing coronary angiography.
Methodology: This prospective observational study was conducted at the Department of Cardiology, Peshawar Institute of Cardiology, from January 2022 to January 2023. A total of 120 adult patients undergoing clinically indicated coronary angiography were consecutively enrolled. Coronary anatomical variations including dominance patterns, myocardial bridging, anomalous coronary origins, coronary tortuosity, and luminal stenosis were documented. Myocardial fibrosis was assessed using cardiac magnetic resonance imaging and surrogate functional parameters. Interventional outcomes were correlated with underlying anatomical variations. Statistical analysis was performed using chi-square tests and multivariate logistic regression.
Results: Myocardial fibrosis was detected in 43.3% of patients. Myocardial bridging, anomalous coronary origins, coronary tortuosity, and significant luminal stenosis were significantly associated with myocardial fibrosis (p < 0.05). Patients with anatomical variations demonstrated significantly higher rates of percutaneous coronary intervention, multi-vessel revascularization, increased procedural complexity, and peri-procedural ischemic changes.
Conclusion: Coronary artery anatomical variations are significantly associated with myocardial fibrosis and adversely influence interventional outcomes. Recognition of these variations may enhance risk stratification and guide individualized interventional planning.
References
Badawy, M.M., et al., Potential Effects of Bisphenol A on the Heart and Coronary Artery of Adult Male Rats and the Possible Role of L‐Carnitine. 2022. 2022(1): p. 7760594.
de Carvalho, F.P. and C.F.J.R. Azevedo, Comprehensive assessment of endomyocardial fibrosis with cardiac MRI: morphology, function, and tissue characterization. 2020. 40(2): p. 336-353.
Dusenbery, S.M., et al., Myocardial fibrosis in patients with a history of Kawasaki disease. 2021. 32: p. 100713.
Giordano, C., et al., Myocardial fibrosis: morphologic patterns and role of imaging in diagnosis and prognostication. 2022. 56: p. 107391.
Gómez, F.A., P.L. Forero, and L.E.J.I.J.o.M. Ballesteros, Microscopic Analysis of the Myocardial Bridges and their Relationship with Atheromatous Plaque. 2021. 39(1).
Johny, E. and P.J.J.o.v.e.J. Dutta, Left coronary artery ligation: a Surgical Murine Model of myocardial infarction. 2022(186): p. 10.3791/64387.
Karamitsos, T.D., et al., Myocardial tissue characterization and fibrosis by imaging. 2020. 13(5): p. 1221-1234.
Kareinen, I., et al., Anatomical variations and pathological changes in the hearts of free-ranging Eurasian lynx (Lynx lynx) in Finland. 2020. 66(1): p. 21.
Krishnan, A., et al., The role of epicardial adipose tissue in the development of atrial fibrillation, coronary artery disease and chronic heart failure in the context of obesity and type 2 diabetes mellitus: a narrative review. 2022. 9(7): p. 217.
Lisi, M., et al., Detection of myocardial fibrosis by speckle-tracking echocardiography: from prediction to clinical applications. 2022. 27(5): p. 1857-1867.
Liu, B., et al., Myocardial fibrosis in asymptomatic and symptomatic chronic severe primary mitral regurgitation and relationship to tissue characterisation and left ventricular function on cardiovascular magnetic resonance. 2020. 22(1): p. 86.
Mandoli, G.E., et al., Novel approaches in cardiac imaging for non-invasive assessment of left heart myocardial fibrosis. 2021. 8: p. 614235.
Markousis‐Mavrogenis, G., et al., Coronary microvascular disease: the “meeting point” of cardiology, rheumatology and endocrinology. 2022. 52(5): p. e13737.
Moittié, S., et al., Discovery of os cordis in the cardiac skeleton of chimpanzees (Pan troglodytes). 2020. 10(1): p. 9417.
Nwabuo, C.C. and R.S.J.C.h.r. Vasan, Pathophysiology of hypertensive heart disease: beyond left ventricular hypertrophy. 2020. 22(2): p. 11.
Scavello, F., et al., Soluble receptor for advanced glycation end-products regulates age-associated cardiac fibrosis. 2021. 17(10): p. 2399.
Sohns, C. and N.F.J.E.h.j. Marrouche, Atrial fibrillation and cardiac fibrosis. 2020. 41(10): p. 1123-1131.
Sonaglioni, A., et al., Molecular approaches and echocardiographic deformation imaging in detecting myocardial fibrosis. 2022. 23(18): p. 10944.
Vähätalo, J.H., et al., Genetic variants associated with sudden cardiac death in victims with single vessel coronary artery disease and left ventricular hypertrophy with or without fibrosis. 2022. 8: p. 755062.
Zhu, L., et al., Detection of myocardial fibrosis: Where we stand. 2022. 9: p. 926378.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2023 Shehla Khatoon, Amna Halima, Zainab Rehman, Sayyed Abubakkar, Sikandar Hayat
This work is licensed under a Creative Commons Attribution 4.0 International License.
